Mid West One Financial Group, Inc. Horizon Therapeutics Public LTD CO Transaction History

Mid West One Financial Group, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$62.39 - $113.8 $228,721 - $417,190	-3,666 Reduced 17.91%	16,802 $1.91 Million
Q3 2022 Nov 14, 2022	BUY	$58.92 - $84.67 $487,916 - $701,152	8,281 Added 67.95%	20,468 $1.27 Million
Q2 2022 Aug 16, 2022	SELL	$79.4 - $116.36 $21,835 - $31,999	-275 Reduced 2.21%	12,187 $972,000
Q1 2022 May 17, 2022	BUY	$86.42 - $109.81 $177,074 - $225,000	2,049 Added 19.68%	12,462 $1.31 Million
Q4 2021 Feb 15, 2022	BUY	$98.56 - $119.91 $465,794 - $566,694	4,726 Added 83.1%	10,413 $1.12 Million
Q3 2021 Nov 15, 2021	BUY	$91.91 - $110.37 $16,819 - $20,197	183 Added 3.32%	5,687 $623,000
Q2 2021 Aug 17, 2021	BUY	$86.24 - $95.92 $71,579 - $79,613	830 Added 17.76%	5,504 $515,000
Q1 2021 May 18, 2021	BUY	$71.83 - $95.48 $335,733 - $446,273	4,674 New	4,674 $430,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Mid West One Financial Group, Inc., based on Form 13F filings with the SEC.

Stay updated on Mid West One Financial Group, Inc. with notifications on news.